Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

Wake Forest University at Clemmons, Clemmons

Wake Forest University Health Sciences, Winston-Salem

Wake Forest Baptist Health - Wilkes Medical Center, Wilkesboro

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami

UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables

UM Sylvester Comprehensive Cancer Center at Kendall, Miami

UM Sylvester Comprehensive Cancer Center at Plantation, Plantation

UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach

Vanderbilt University/Ingram Cancer Center, Nashville

Ohio State University Comprehensive Cancer Center, Columbus

Northwestern University, Chicago

University of Kansas Cancer Center - Lee's Summit, Lee's Summit

University Health Truman Medical Center, Kansas City

University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City

University of Kansas Cancer Center - North, Kansas City

Lawrence Memorial Hospital, Lawrence

The University of Kansas Cancer Center - Olathe, Olathe

University of Kansas Clinical Research Center, Fairway

University of Kansas Hospital-Westwood Cancer Center, Westwood

University of Kansas Cancer Center-Overland Park, Overland Park

University of Kansas Health System Saint Francis Campus, Topeka

Mercy Hospital Pittsburg, Pittsburg

Salina Regional Health Center, Salina

HaysMed, Hays

University of Oklahoma Health Sciences Center, Oklahoma City

Huntsman Cancer Institute/University of Utah, Salt Lake City

Los Angeles General Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

City of Hope Comprehensive Cancer Center, Duarte

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange

University of California Davis Comprehensive Cancer Center, Sacramento